nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—HTR1A—stomach cancer	0.371	1	CbGaD
Trifluoperazine—XDH—Doxorubicin—stomach cancer	0.0716	0.381	CbGbCtD
Trifluoperazine—ABCB1—Mitomycin—stomach cancer	0.0582	0.309	CbGbCtD
Trifluoperazine—CYP1A2—Fluorouracil—stomach cancer	0.0164	0.0871	CbGbCtD
Trifluoperazine—ABCB1—Irinotecan—stomach cancer	0.0149	0.0794	CbGbCtD
Trifluoperazine—ABCB1—Docetaxel—stomach cancer	0.0109	0.0582	CbGbCtD
Trifluoperazine—ABCB1—Doxorubicin—stomach cancer	0.00816	0.0434	CbGbCtD
Trifluoperazine—ABCB1—Methotrexate—stomach cancer	0.0079	0.042	CbGbCtD
Trifluoperazine—HTR2A—myenteric nerve plexus—stomach cancer	0.0051	0.0465	CbGeAlD
Trifluoperazine—EBPL—epithelium—stomach cancer	0.00368	0.0336	CbGeAlD
Trifluoperazine—HTR2A—vagus nerve—stomach cancer	0.0034	0.031	CbGeAlD
Trifluoperazine—HTR2A—vein—stomach cancer	0.00328	0.0299	CbGeAlD
Trifluoperazine—S100A4—hematopoietic system—stomach cancer	0.00318	0.029	CbGeAlD
Trifluoperazine—S100A4—epithelium—stomach cancer	0.00291	0.0265	CbGeAlD
Trifluoperazine—S100A4—smooth muscle tissue—stomach cancer	0.0028	0.0255	CbGeAlD
Trifluoperazine—UGT1A4—hematopoietic system—stomach cancer	0.00279	0.0255	CbGeAlD
Trifluoperazine—TNNC1—hematopoietic system—stomach cancer	0.00268	0.0244	CbGeAlD
Trifluoperazine—S100A4—pancreas—stomach cancer	0.00259	0.0236	CbGeAlD
Trifluoperazine—EBPL—endocrine gland—stomach cancer	0.00231	0.0211	CbGeAlD
Trifluoperazine—S100A4—lymphoid tissue—stomach cancer	0.00224	0.0204	CbGeAlD
Trifluoperazine—EBP—endocrine gland—stomach cancer	0.00222	0.0202	CbGeAlD
Trifluoperazine—S100A4—digestive system—stomach cancer	0.00221	0.0202	CbGeAlD
Trifluoperazine—CALY—endocrine gland—stomach cancer	0.00212	0.0193	CbGeAlD
Trifluoperazine—EBPL—liver—stomach cancer	0.00209	0.019	CbGeAlD
Trifluoperazine—S100A4—bone marrow—stomach cancer	0.00204	0.0186	CbGeAlD
Trifluoperazine—EBP—liver—stomach cancer	0.002	0.0182	CbGeAlD
Trifluoperazine—UGT1A4—digestive system—stomach cancer	0.00194	0.0177	CbGeAlD
Trifluoperazine—S100A4—endocrine gland—stomach cancer	0.00183	0.0167	CbGeAlD
Trifluoperazine—CALM2—blood vessel—stomach cancer	0.00172	0.0157	CbGeAlD
Trifluoperazine—CALM1—blood vessel—stomach cancer	0.00171	0.0156	CbGeAlD
Trifluoperazine—S100A4—liver—stomach cancer	0.00165	0.015	CbGeAlD
Trifluoperazine—CALM2—gall bladder—stomach cancer	0.00162	0.0147	CbGeAlD
Trifluoperazine—UGT1A4—endocrine gland—stomach cancer	0.0016	0.0146	CbGeAlD
Trifluoperazine—EBPL—lymph node—stomach cancer	0.0016	0.0146	CbGeAlD
Trifluoperazine—CALY—lymph node—stomach cancer	0.00146	0.0133	CbGeAlD
Trifluoperazine—UGT1A4—liver—stomach cancer	0.00145	0.0132	CbGeAlD
Trifluoperazine—XDH—digestive system—stomach cancer	0.00142	0.0129	CbGeAlD
Trifluoperazine—S100A4—lymph node—stomach cancer	0.00126	0.0115	CbGeAlD
Trifluoperazine—XDH—endocrine gland—stomach cancer	0.00117	0.0107	CbGeAlD
Trifluoperazine—TNNC1—lymph node—stomach cancer	0.00106	0.00969	CbGeAlD
Trifluoperazine—XDH—liver—stomach cancer	0.00105	0.00962	CbGeAlD
Trifluoperazine—HTR2A—blood vessel—stomach cancer	0.00104	0.0095	CbGeAlD
Trifluoperazine—CALM3—smooth muscle tissue—stomach cancer	0.00103	0.00936	CbGeAlD
Trifluoperazine—CALM3—pancreas—stomach cancer	0.000949	0.00865	CbGeAlD
Trifluoperazine—HTR1A—hematopoietic system—stomach cancer	0.000931	0.00849	CbGeAlD
Trifluoperazine—SIGMAR1—smooth muscle tissue—stomach cancer	0.000917	0.00837	CbGeAlD
Trifluoperazine—CALM2—hematopoietic system—stomach cancer	0.000915	0.00835	CbGeAlD
Trifluoperazine—CALM1—hematopoietic system—stomach cancer	0.000911	0.00831	CbGeAlD
Trifluoperazine—ADRA1A—hematopoietic system—stomach cancer	0.000858	0.00783	CbGeAlD
Trifluoperazine—SIGMAR1—pancreas—stomach cancer	0.000848	0.00773	CbGeAlD
Trifluoperazine—CALM2—epithelium—stomach cancer	0.000836	0.00763	CbGeAlD
Trifluoperazine—CALM1—epithelium—stomach cancer	0.000832	0.00759	CbGeAlD
Trifluoperazine—CALM2—smooth muscle tissue—stomach cancer	0.000806	0.00735	CbGeAlD
Trifluoperazine—CALM1—smooth muscle tissue—stomach cancer	0.000802	0.00732	CbGeAlD
Trifluoperazine—ADRA1A—epithelium—stomach cancer	0.000784	0.00716	CbGeAlD
Trifluoperazine—CALM3—bone marrow—stomach cancer	0.000747	0.00681	CbGeAlD
Trifluoperazine—CALM2—pancreas—stomach cancer	0.000745	0.0068	CbGeAlD
Trifluoperazine—CALM1—pancreas—stomach cancer	0.000742	0.00676	CbGeAlD
Trifluoperazine—CYP1A2—hematopoietic system—stomach cancer	0.00071	0.00647	CbGeAlD
Trifluoperazine—ABCB1—blood vessel—stomach cancer	0.000683	0.00623	CbGeAlD
Trifluoperazine—SIGMAR1—bone marrow—stomach cancer	0.000668	0.00609	CbGeAlD
Trifluoperazine—HRH1—hematopoietic system—stomach cancer	0.000664	0.00606	CbGeAlD
Trifluoperazine—CHRM2—endocrine gland—stomach cancer	0.000659	0.00601	CbGeAlD
Trifluoperazine—CALM2—lymphoid tissue—stomach cancer	0.000644	0.00588	CbGeAlD
Trifluoperazine—CALM1—lymphoid tissue—stomach cancer	0.000641	0.00585	CbGeAlD
Trifluoperazine—CALM2—digestive system—stomach cancer	0.000636	0.0058	CbGeAlD
Trifluoperazine—CALM1—digestive system—stomach cancer	0.000633	0.00578	CbGeAlD
Trifluoperazine—HRH1—epithelium—stomach cancer	0.000607	0.00554	CbGeAlD
Trifluoperazine—ADRA1A—lymphoid tissue—stomach cancer	0.000604	0.00551	CbGeAlD
Trifluoperazine—CALM3—liver—stomach cancer	0.000604	0.00551	CbGeAlD
Trifluoperazine—CALM2—bone marrow—stomach cancer	0.000587	0.00535	CbGeAlD
Trifluoperazine—HRH1—smooth muscle tissue—stomach cancer	0.000585	0.00534	CbGeAlD
Trifluoperazine—CALM1—bone marrow—stomach cancer	0.000584	0.00533	CbGeAlD
Trifluoperazine—HTR2A—hematopoietic system—stomach cancer	0.000555	0.00506	CbGeAlD
Trifluoperazine—SIGMAR1—liver—stomach cancer	0.000539	0.00492	CbGeAlD
Trifluoperazine—HTR1A—endocrine gland—stomach cancer	0.000535	0.00488	CbGeAlD
Trifluoperazine—CALM2—endocrine gland—stomach cancer	0.000526	0.0048	CbGeAlD
Trifluoperazine—CALM1—endocrine gland—stomach cancer	0.000523	0.00477	CbGeAlD
Trifluoperazine—HTR2A—epithelium—stomach cancer	0.000507	0.00463	CbGeAlD
Trifluoperazine—CYP1A2—digestive system—stomach cancer	0.000493	0.0045	CbGeAlD
Trifluoperazine—ADRA1A—endocrine gland—stomach cancer	0.000493	0.0045	CbGeAlD
Trifluoperazine—Promethazine—HRH4—stomach cancer	0.00049	0.0873	CrCbGaD
Trifluoperazine—HTR2A—smooth muscle tissue—stomach cancer	0.000489	0.00446	CbGeAlD
Trifluoperazine—DRD2—endocrine gland—stomach cancer	0.000483	0.00441	CbGeAlD
Trifluoperazine—Loxapine—HRH4—stomach cancer	0.000481	0.0855	CrCbGaD
Trifluoperazine—CALM2—liver—stomach cancer	0.000474	0.00432	CbGeAlD
Trifluoperazine—CALM1—liver—stomach cancer	0.000472	0.0043	CbGeAlD
Trifluoperazine—CALM3—lymph node—stomach cancer	0.000463	0.00422	CbGeAlD
Trifluoperazine—HRH1—digestive system—stomach cancer	0.000462	0.00421	CbGeAlD
Trifluoperazine—ADRA1A—liver—stomach cancer	0.000445	0.00406	CbGeAlD
Trifluoperazine—SIGMAR1—lymph node—stomach cancer	0.000414	0.00377	CbGeAlD
Trifluoperazine—Nausea—Mitomycin—stomach cancer	0.000411	0.00322	CcSEcCtD
Trifluoperazine—CYP1A2—endocrine gland—stomach cancer	0.000408	0.00372	CbGeAlD
Trifluoperazine—Clozapine—HRH4—stomach cancer	0.000404	0.0718	CrCbGaD
Trifluoperazine—Gait disturbance—Epirubicin—stomach cancer	0.000403	0.00315	CcSEcCtD
Trifluoperazine—Antrafenine—PTGS2—stomach cancer	0.000397	0.0707	CrCbGaD
Trifluoperazine—Aplastic anaemia—Methotrexate—stomach cancer	0.000394	0.00308	CcSEcCtD
Trifluoperazine—Hepatocellular injury—Epirubicin—stomach cancer	0.000393	0.00307	CcSEcCtD
Trifluoperazine—Cardiac arrest—Capecitabine—stomach cancer	0.000389	0.00304	CcSEcCtD
Trifluoperazine—Urinary retention—Capecitabine—stomach cancer	0.000389	0.00304	CcSEcCtD
Trifluoperazine—Dyskinesia—Doxorubicin—stomach cancer	0.000387	0.00302	CcSEcCtD
Trifluoperazine—HTR2A—digestive system—stomach cancer	0.000386	0.00352	CbGeAlD
Trifluoperazine—HRH1—endocrine gland—stomach cancer	0.000382	0.00348	CbGeAlD
Trifluoperazine—Chlorpromazine—HRH4—stomach cancer	0.00038	0.0676	CrCbGaD
Trifluoperazine—Gynaecomastia—Methotrexate—stomach cancer	0.000376	0.00294	CcSEcCtD
Trifluoperazine—Gait disturbance—Doxorubicin—stomach cancer	0.000373	0.00291	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Epirubicin—stomach cancer	0.000369	0.00288	CcSEcCtD
Trifluoperazine—CYP1A2—liver—stomach cancer	0.000368	0.00335	CbGeAlD
Trifluoperazine—Dysphagia—Docetaxel—stomach cancer	0.000366	0.00286	CcSEcCtD
Trifluoperazine—Hepatocellular injury—Doxorubicin—stomach cancer	0.000364	0.00284	CcSEcCtD
Trifluoperazine—ABCB1—hematopoietic system—stomach cancer	0.000364	0.00332	CbGeAlD
Trifluoperazine—CALM2—lymph node—stomach cancer	0.000363	0.00332	CbGeAlD
Trifluoperazine—CALM1—lymph node—stomach cancer	0.000362	0.0033	CbGeAlD
Trifluoperazine—Muscular weakness—Capecitabine—stomach cancer	0.000361	0.00282	CcSEcCtD
Trifluoperazine—Bronchospasm—Docetaxel—stomach cancer	0.00036	0.00281	CcSEcCtD
Trifluoperazine—Muscle spasms—Irinotecan—stomach cancer	0.000354	0.00277	CcSEcCtD
Trifluoperazine—Dysphagia—Capecitabine—stomach cancer	0.000354	0.00277	CcSEcCtD
Trifluoperazine—Asthma—Capecitabine—stomach cancer	0.000354	0.00277	CcSEcCtD
Trifluoperazine—Erythema—Fluorouracil—stomach cancer	0.000353	0.00276	CcSEcCtD
Trifluoperazine—Bronchospasm—Capecitabine—stomach cancer	0.000348	0.00272	CcSEcCtD
Trifluoperazine—Photosensitivity—Methotrexate—stomach cancer	0.000347	0.00271	CcSEcCtD
Trifluoperazine—Pancytopenia—Docetaxel—stomach cancer	0.000347	0.00271	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Doxorubicin—stomach cancer	0.000341	0.00267	CcSEcCtD
Trifluoperazine—Pancytopenia—Capecitabine—stomach cancer	0.000336	0.00263	CcSEcCtD
Trifluoperazine—Weight increased—Docetaxel—stomach cancer	0.000333	0.0026	CcSEcCtD
Trifluoperazine—Vision blurred—Fluorouracil—stomach cancer	0.000333	0.0026	CcSEcCtD
Trifluoperazine—ABCB1—epithelium—stomach cancer	0.000332	0.00303	CbGeAlD
Trifluoperazine—Leukopenia—Irinotecan—stomach cancer	0.00033	0.00258	CcSEcCtD
Trifluoperazine—Photosensitivity—Epirubicin—stomach cancer	0.000325	0.00254	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Methotrexate—stomach cancer	0.000323	0.00253	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Capecitabine—stomach cancer	0.000323	0.00253	CcSEcCtD
Trifluoperazine—Weight increased—Capecitabine—stomach cancer	0.000322	0.00252	CcSEcCtD
Trifluoperazine—Cough—Irinotecan—stomach cancer	0.000322	0.00251	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Capecitabine—stomach cancer	0.000319	0.0025	CcSEcCtD
Trifluoperazine—HTR2A—endocrine gland—stomach cancer	0.000319	0.00291	CbGeAlD
Trifluoperazine—Jaundice—Docetaxel—stomach cancer	0.000318	0.00248	CcSEcCtD
Trifluoperazine—Eczema—Epirubicin—stomach cancer	0.000317	0.00248	CcSEcCtD
Trifluoperazine—Leukopenia—Fluorouracil—stomach cancer	0.000316	0.00247	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Methotrexate—stomach cancer	0.000315	0.00246	CcSEcCtD
Trifluoperazine—Jaundice—Capecitabine—stomach cancer	0.000308	0.0024	CcSEcCtD
Trifluoperazine—Convulsion—Fluorouracil—stomach cancer	0.000306	0.00239	CcSEcCtD
Trifluoperazine—Agranulocytosis—Docetaxel—stomach cancer	0.000304	0.00238	CcSEcCtD
Trifluoperazine—Increased appetite—Epirubicin—stomach cancer	0.000304	0.00237	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Epirubicin—stomach cancer	0.000302	0.00236	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Irinotecan—stomach cancer	0.000301	0.00235	CcSEcCtD
Trifluoperazine—Photosensitivity—Doxorubicin—stomach cancer	0.000301	0.00235	CcSEcCtD
Trifluoperazine—ABCB1—pancreas—stomach cancer	0.000296	0.0027	CbGeAlD
Trifluoperazine—Anaphylactoid reaction—Epirubicin—stomach cancer	0.000295	0.0023	CcSEcCtD
Trifluoperazine—Agranulocytosis—Capecitabine—stomach cancer	0.000294	0.0023	CcSEcCtD
Trifluoperazine—Eczema—Doxorubicin—stomach cancer	0.000294	0.0023	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Epirubicin—stomach cancer	0.000292	0.00229	CcSEcCtD
Trifluoperazine—Oedema peripheral—Docetaxel—stomach cancer	0.000288	0.00225	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Fluorouracil—stomach cancer	0.000288	0.00225	CcSEcCtD
Trifluoperazine—HTR2A—liver—stomach cancer	0.000287	0.00262	CbGeAlD
Trifluoperazine—Anorexia—Irinotecan—stomach cancer	0.000287	0.00224	CcSEcCtD
Trifluoperazine—Hypotension—Irinotecan—stomach cancer	0.000281	0.0022	CcSEcCtD
Trifluoperazine—Increased appetite—Doxorubicin—stomach cancer	0.000281	0.0022	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Doxorubicin—stomach cancer	0.00028	0.00219	CcSEcCtD
Trifluoperazine—Oedema peripheral—Capecitabine—stomach cancer	0.000279	0.00218	CcSEcCtD
Trifluoperazine—Anorexia—Fluorouracil—stomach cancer	0.000275	0.00215	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.000273	0.00213	CcSEcCtD
Trifluoperazine—Insomnia—Irinotecan—stomach cancer	0.000272	0.00213	CcSEcCtD
Trifluoperazine—Cardiac arrest—Epirubicin—stomach cancer	0.000271	0.00212	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Doxorubicin—stomach cancer	0.00027	0.00211	CcSEcCtD
Trifluoperazine—Hypotension—Fluorouracil—stomach cancer	0.000269	0.0021	CcSEcCtD
Trifluoperazine—Dyspnoea—Irinotecan—stomach cancer	0.000268	0.0021	CcSEcCtD
Trifluoperazine—Somnolence—Irinotecan—stomach cancer	0.000267	0.00209	CcSEcCtD
Trifluoperazine—HRH1—lymph node—stomach cancer	0.000264	0.00241	CbGeAlD
Trifluoperazine—Asthma—Methotrexate—stomach cancer	0.000263	0.00206	CcSEcCtD
Trifluoperazine—Decreased appetite—Irinotecan—stomach cancer	0.000261	0.00204	CcSEcCtD
Trifluoperazine—Eosinophilia—Methotrexate—stomach cancer	0.000261	0.00204	CcSEcCtD
Trifluoperazine—Insomnia—Fluorouracil—stomach cancer	0.00026	0.00204	CcSEcCtD
Trifluoperazine—Fatigue—Irinotecan—stomach cancer	0.000259	0.00203	CcSEcCtD
Trifluoperazine—Constipation—Irinotecan—stomach cancer	0.000257	0.00201	CcSEcCtD
Trifluoperazine—Dyspnoea—Fluorouracil—stomach cancer	0.000257	0.00201	CcSEcCtD
Trifluoperazine—Somnolence—Fluorouracil—stomach cancer	0.000256	0.002	CcSEcCtD
Trifluoperazine—ABCB1—lymphoid tissue—stomach cancer	0.000256	0.00233	CbGeAlD
Trifluoperazine—Clomipramine—GSTP1—stomach cancer	0.000255	0.0453	CrCbGaD
Trifluoperazine—Erythema—Docetaxel—stomach cancer	0.000255	0.00199	CcSEcCtD
Trifluoperazine—ABCB1—digestive system—stomach cancer	0.000253	0.00231	CbGeAlD
Trifluoperazine—Muscular weakness—Epirubicin—stomach cancer	0.000252	0.00197	CcSEcCtD
Trifluoperazine—Cardiac arrest—Doxorubicin—stomach cancer	0.000251	0.00196	CcSEcCtD
Trifluoperazine—Decreased appetite—Fluorouracil—stomach cancer	0.00025	0.00196	CcSEcCtD
Trifluoperazine—Pancytopenia—Methotrexate—stomach cancer	0.00025	0.00196	CcSEcCtD
Trifluoperazine—Erythema—Capecitabine—stomach cancer	0.000247	0.00193	CcSEcCtD
Trifluoperazine—Asthma—Epirubicin—stomach cancer	0.000247	0.00193	CcSEcCtD
Trifluoperazine—Dysphagia—Epirubicin—stomach cancer	0.000247	0.00193	CcSEcCtD
Trifluoperazine—Muscle spasms—Docetaxel—stomach cancer	0.000245	0.00191	CcSEcCtD
Trifluoperazine—Eosinophilia—Epirubicin—stomach cancer	0.000244	0.00191	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Methotrexate—stomach cancer	0.000243	0.0019	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Methotrexate—stomach cancer	0.00024	0.00188	CcSEcCtD
Trifluoperazine—Body temperature increased—Irinotecan—stomach cancer	0.000238	0.00186	CcSEcCtD
Trifluoperazine—Muscle spasms—Capecitabine—stomach cancer	0.000237	0.00185	CcSEcCtD
Trifluoperazine—Drowsiness—Methotrexate—stomach cancer	0.000235	0.00184	CcSEcCtD
Trifluoperazine—Pancytopenia—Epirubicin—stomach cancer	0.000234	0.00183	CcSEcCtD
Trifluoperazine—Nefazodone—HTR1A—stomach cancer	0.000233	0.0415	CrCbGaD
Trifluoperazine—ABCB1—bone marrow—stomach cancer	0.000233	0.00213	CbGeAlD
Trifluoperazine—Muscular weakness—Doxorubicin—stomach cancer	0.000233	0.00182	CcSEcCtD
Trifluoperazine—Vision blurred—Capecitabine—stomach cancer	0.000232	0.00182	CcSEcCtD
Trifluoperazine—Tremor—Capecitabine—stomach cancer	0.000231	0.00181	CcSEcCtD
Trifluoperazine—Urticaria—Fluorouracil—stomach cancer	0.000229	0.00179	CcSEcCtD
Trifluoperazine—Asthma—Doxorubicin—stomach cancer	0.000228	0.00178	CcSEcCtD
Trifluoperazine—Dysphagia—Doxorubicin—stomach cancer	0.000228	0.00178	CcSEcCtD
Trifluoperazine—Leukopenia—Docetaxel—stomach cancer	0.000228	0.00178	CcSEcCtD
Trifluoperazine—Body temperature increased—Fluorouracil—stomach cancer	0.000228	0.00178	CcSEcCtD
Trifluoperazine—Eosinophilia—Doxorubicin—stomach cancer	0.000226	0.00177	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Epirubicin—stomach cancer	0.000225	0.00176	CcSEcCtD
Trifluoperazine—Weight increased—Epirubicin—stomach cancer	0.000224	0.00175	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Epirubicin—stomach cancer	0.000222	0.00174	CcSEcCtD
Trifluoperazine—Cough—Docetaxel—stomach cancer	0.000222	0.00174	CcSEcCtD
Trifluoperazine—Hypersensitivity—Irinotecan—stomach cancer	0.000222	0.00173	CcSEcCtD
Trifluoperazine—Leukopenia—Capecitabine—stomach cancer	0.000221	0.00173	CcSEcCtD
Trifluoperazine—Convulsion—Docetaxel—stomach cancer	0.000221	0.00173	CcSEcCtD
Trifluoperazine—Drowsiness—Epirubicin—stomach cancer	0.00022	0.00172	CcSEcCtD
Trifluoperazine—Agranulocytosis—Methotrexate—stomach cancer	0.000219	0.00171	CcSEcCtD
Trifluoperazine—Pancytopenia—Doxorubicin—stomach cancer	0.000217	0.00169	CcSEcCtD
Trifluoperazine—Trazodone—HTR1A—stomach cancer	0.000216	0.0384	CrCbGaD
Trifluoperazine—Asthenia—Irinotecan—stomach cancer	0.000216	0.00169	CcSEcCtD
Trifluoperazine—Cough—Capecitabine—stomach cancer	0.000215	0.00168	CcSEcCtD
Trifluoperazine—Jaundice—Epirubicin—stomach cancer	0.000214	0.00168	CcSEcCtD
Trifluoperazine—Hypersensitivity—Fluorouracil—stomach cancer	0.000212	0.00166	CcSEcCtD
Trifluoperazine—Dry mouth—Docetaxel—stomach cancer	0.000212	0.00166	CcSEcCtD
Trifluoperazine—Acepromazine—HTR1A—stomach cancer	0.00021	0.0374	CrCbGaD
Trifluoperazine—ABCB1—endocrine gland—stomach cancer	0.000209	0.00191	CbGeAlD
Trifluoperazine—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000208	0.00163	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Docetaxel—stomach cancer	0.000208	0.00162	CcSEcCtD
Trifluoperazine—Weight increased—Doxorubicin—stomach cancer	0.000208	0.00162	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Doxorubicin—stomach cancer	0.000206	0.00161	CcSEcCtD
Trifluoperazine—Thioproperazine—HTR1A—stomach cancer	0.000206	0.0366	CrCbGaD
Trifluoperazine—Dry mouth—Capecitabine—stomach cancer	0.000205	0.00161	CcSEcCtD
Trifluoperazine—Agranulocytosis—Epirubicin—stomach cancer	0.000205	0.0016	CcSEcCtD
Trifluoperazine—Pruritus—Fluorouracil—stomach cancer	0.000204	0.00159	CcSEcCtD
Trifluoperazine—Drowsiness—Doxorubicin—stomach cancer	0.000203	0.00159	CcSEcCtD
Trifluoperazine—Pipotiazine—HTR1A—stomach cancer	0.000202	0.036	CrCbGaD
Trifluoperazine—Thiothixene—HTR1A—stomach cancer	0.000202	0.036	CrCbGaD
Trifluoperazine—Skin disorder—Docetaxel—stomach cancer	0.000202	0.00158	CcSEcCtD
Trifluoperazine—Mesoridazine—HTR1A—stomach cancer	0.0002	0.0355	CrCbGaD
Trifluoperazine—Dizziness—Irinotecan—stomach cancer	0.000199	0.00155	CcSEcCtD
Trifluoperazine—Jaundice—Doxorubicin—stomach cancer	0.000198	0.00155	CcSEcCtD
Trifluoperazine—Anorexia—Docetaxel—stomach cancer	0.000198	0.00155	CcSEcCtD
Trifluoperazine—Skin disorder—Capecitabine—stomach cancer	0.000195	0.00153	CcSEcCtD
Trifluoperazine—Oedema peripheral—Epirubicin—stomach cancer	0.000194	0.00152	CcSEcCtD
Trifluoperazine—Hypotension—Docetaxel—stomach cancer	0.000194	0.00152	CcSEcCtD
Trifluoperazine—Anorexia—Capecitabine—stomach cancer	0.000192	0.0015	CcSEcCtD
Trifluoperazine—Dizziness—Fluorouracil—stomach cancer	0.00019	0.00149	CcSEcCtD
Trifluoperazine—Agranulocytosis—Doxorubicin—stomach cancer	0.00019	0.00148	CcSEcCtD
Trifluoperazine—Rash—Irinotecan—stomach cancer	0.00019	0.00148	CcSEcCtD
Trifluoperazine—Dermatitis—Irinotecan—stomach cancer	0.000189	0.00148	CcSEcCtD
Trifluoperazine—Headache—Irinotecan—stomach cancer	0.000188	0.00147	CcSEcCtD
Trifluoperazine—ABCB1—liver—stomach cancer	0.000188	0.00172	CbGeAlD
Trifluoperazine—Hypotension—Capecitabine—stomach cancer	0.000188	0.00147	CcSEcCtD
Trifluoperazine—Insomnia—Docetaxel—stomach cancer	0.000188	0.00147	CcSEcCtD
Trifluoperazine—Dyspnoea—Docetaxel—stomach cancer	0.000185	0.00145	CcSEcCtD
Trifluoperazine—Somnolence—Docetaxel—stomach cancer	0.000185	0.00144	CcSEcCtD
Trifluoperazine—Erythema—Methotrexate—stomach cancer	0.000184	0.00144	CcSEcCtD
Trifluoperazine—Insomnia—Capecitabine—stomach cancer	0.000182	0.00142	CcSEcCtD
Trifluoperazine—Rash—Fluorouracil—stomach cancer	0.000182	0.00142	CcSEcCtD
Trifluoperazine—Dermatitis—Fluorouracil—stomach cancer	0.000181	0.00142	CcSEcCtD
Trifluoperazine—Decreased appetite—Docetaxel—stomach cancer	0.000181	0.00141	CcSEcCtD
Trifluoperazine—Headache—Fluorouracil—stomach cancer	0.00018	0.00141	CcSEcCtD
Trifluoperazine—Oedema peripheral—Doxorubicin—stomach cancer	0.00018	0.00141	CcSEcCtD
Trifluoperazine—Dyspnoea—Capecitabine—stomach cancer	0.000179	0.0014	CcSEcCtD
Trifluoperazine—Fatigue—Docetaxel—stomach cancer	0.000179	0.0014	CcSEcCtD
Trifluoperazine—Nausea—Irinotecan—stomach cancer	0.000179	0.0014	CcSEcCtD
Trifluoperazine—Constipation—Docetaxel—stomach cancer	0.000178	0.00139	CcSEcCtD
Trifluoperazine—Decreased appetite—Capecitabine—stomach cancer	0.000175	0.00137	CcSEcCtD
Trifluoperazine—Fluphenazine—HTR1A—stomach cancer	0.000175	0.0311	CrCbGaD
Trifluoperazine—Fatigue—Capecitabine—stomach cancer	0.000174	0.00136	CcSEcCtD
Trifluoperazine—Vision blurred—Methotrexate—stomach cancer	0.000173	0.00135	CcSEcCtD
Trifluoperazine—Constipation—Capecitabine—stomach cancer	0.000172	0.00135	CcSEcCtD
Trifluoperazine—Erythema—Epirubicin—stomach cancer	0.000172	0.00134	CcSEcCtD
Trifluoperazine—Nausea—Fluorouracil—stomach cancer	0.000171	0.00134	CcSEcCtD
Trifluoperazine—Nervousness—Epirubicin—stomach cancer	0.000167	0.0013	CcSEcCtD
Trifluoperazine—Muscle spasms—Epirubicin—stomach cancer	0.000165	0.00129	CcSEcCtD
Trifluoperazine—Body temperature increased—Docetaxel—stomach cancer	0.000164	0.00128	CcSEcCtD
Trifluoperazine—Leukopenia—Methotrexate—stomach cancer	0.000164	0.00128	CcSEcCtD
Trifluoperazine—Vision blurred—Epirubicin—stomach cancer	0.000162	0.00127	CcSEcCtD
Trifluoperazine—Cough—Methotrexate—stomach cancer	0.00016	0.00125	CcSEcCtD
Trifluoperazine—Urticaria—Capecitabine—stomach cancer	0.00016	0.00125	CcSEcCtD
Trifluoperazine—Body temperature increased—Capecitabine—stomach cancer	0.000159	0.00124	CcSEcCtD
Trifluoperazine—Convulsion—Methotrexate—stomach cancer	0.000159	0.00124	CcSEcCtD
Trifluoperazine—Erythema—Doxorubicin—stomach cancer	0.000159	0.00124	CcSEcCtD
Trifluoperazine—Agitation—Epirubicin—stomach cancer	0.000158	0.00123	CcSEcCtD
Trifluoperazine—Loxapine—ADRB1—stomach cancer	0.000155	0.0276	CrCbGaD
Trifluoperazine—Nervousness—Doxorubicin—stomach cancer	0.000154	0.00121	CcSEcCtD
Trifluoperazine—Leukopenia—Epirubicin—stomach cancer	0.000154	0.0012	CcSEcCtD
Trifluoperazine—Hypersensitivity—Docetaxel—stomach cancer	0.000153	0.0012	CcSEcCtD
Trifluoperazine—Muscle spasms—Doxorubicin—stomach cancer	0.000153	0.00119	CcSEcCtD
Trifluoperazine—Thioridazine—HTR1A—stomach cancer	0.000151	0.0268	CrCbGaD
Trifluoperazine—Cough—Epirubicin—stomach cancer	0.00015	0.00117	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Methotrexate—stomach cancer	0.00015	0.00117	CcSEcCtD
Trifluoperazine—Vision blurred—Doxorubicin—stomach cancer	0.00015	0.00117	CcSEcCtD
Trifluoperazine—Asthenia—Docetaxel—stomach cancer	0.000149	0.00117	CcSEcCtD
Trifluoperazine—Convulsion—Epirubicin—stomach cancer	0.000149	0.00116	CcSEcCtD
Trifluoperazine—Hypersensitivity—Capecitabine—stomach cancer	0.000148	0.00116	CcSEcCtD
Trifluoperazine—Pruritus—Docetaxel—stomach cancer	0.000147	0.00115	CcSEcCtD
Trifluoperazine—Agitation—Doxorubicin—stomach cancer	0.000146	0.00114	CcSEcCtD
Trifluoperazine—Skin disorder—Methotrexate—stomach cancer	0.000146	0.00114	CcSEcCtD
Trifluoperazine—ABCB1—lymph node—stomach cancer	0.000144	0.00132	CbGeAlD
Trifluoperazine—Asthenia—Capecitabine—stomach cancer	0.000144	0.00113	CcSEcCtD
Trifluoperazine—Dry mouth—Epirubicin—stomach cancer	0.000143	0.00112	CcSEcCtD
Trifluoperazine—Anorexia—Methotrexate—stomach cancer	0.000143	0.00112	CcSEcCtD
Trifluoperazine—Pruritus—Capecitabine—stomach cancer	0.000142	0.00111	CcSEcCtD
Trifluoperazine—Leukopenia—Doxorubicin—stomach cancer	0.000142	0.00111	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Epirubicin—stomach cancer	0.00014	0.0011	CcSEcCtD
Trifluoperazine—Hypotension—Methotrexate—stomach cancer	0.00014	0.00109	CcSEcCtD
Trifluoperazine—Loxapine—HTR1A—stomach cancer	0.000139	0.0247	CrCbGaD
Trifluoperazine—Cough—Doxorubicin—stomach cancer	0.000139	0.00108	CcSEcCtD
Trifluoperazine—Perphenazine—HTR1A—stomach cancer	0.000138	0.0246	CrCbGaD
Trifluoperazine—Convulsion—Doxorubicin—stomach cancer	0.000138	0.00108	CcSEcCtD
Trifluoperazine—Dizziness—Docetaxel—stomach cancer	0.000137	0.00107	CcSEcCtD
Trifluoperazine—Skin disorder—Epirubicin—stomach cancer	0.000136	0.00106	CcSEcCtD
Trifluoperazine—Quetiapine—HTR1A—stomach cancer	0.000136	0.0241	CrCbGaD
Trifluoperazine—Insomnia—Methotrexate—stomach cancer	0.000136	0.00106	CcSEcCtD
Trifluoperazine—Clozapine—CYP2A6—stomach cancer	0.000134	0.0239	CrCbGaD
Trifluoperazine—Anorexia—Epirubicin—stomach cancer	0.000134	0.00104	CcSEcCtD
Trifluoperazine—Dyspnoea—Methotrexate—stomach cancer	0.000134	0.00104	CcSEcCtD
Trifluoperazine—Somnolence—Methotrexate—stomach cancer	0.000133	0.00104	CcSEcCtD
Trifluoperazine—Dizziness—Capecitabine—stomach cancer	0.000133	0.00104	CcSEcCtD
Trifluoperazine—Dry mouth—Doxorubicin—stomach cancer	0.000132	0.00103	CcSEcCtD
Trifluoperazine—Rash—Docetaxel—stomach cancer	0.000131	0.00102	CcSEcCtD
Trifluoperazine—Hypotension—Epirubicin—stomach cancer	0.000131	0.00102	CcSEcCtD
Trifluoperazine—Dermatitis—Docetaxel—stomach cancer	0.000131	0.00102	CcSEcCtD
Trifluoperazine—Decreased appetite—Methotrexate—stomach cancer	0.00013	0.00102	CcSEcCtD
Trifluoperazine—Headache—Docetaxel—stomach cancer	0.00013	0.00102	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Doxorubicin—stomach cancer	0.00013	0.00101	CcSEcCtD
Trifluoperazine—Fatigue—Methotrexate—stomach cancer	0.000129	0.00101	CcSEcCtD
Trifluoperazine—Rash—Capecitabine—stomach cancer	0.000127	0.000992	CcSEcCtD
Trifluoperazine—Insomnia—Epirubicin—stomach cancer	0.000127	0.000991	CcSEcCtD
Trifluoperazine—Dermatitis—Capecitabine—stomach cancer	0.000127	0.000991	CcSEcCtD
Trifluoperazine—Headache—Capecitabine—stomach cancer	0.000126	0.000986	CcSEcCtD
Trifluoperazine—Skin disorder—Doxorubicin—stomach cancer	0.000126	0.000985	CcSEcCtD
Trifluoperazine—Dyspnoea—Epirubicin—stomach cancer	0.000125	0.000977	CcSEcCtD
Trifluoperazine—Somnolence—Epirubicin—stomach cancer	0.000125	0.000974	CcSEcCtD
Trifluoperazine—Anorexia—Doxorubicin—stomach cancer	0.000124	0.000967	CcSEcCtD
Trifluoperazine—Nausea—Docetaxel—stomach cancer	0.000123	0.000965	CcSEcCtD
Trifluoperazine—Decreased appetite—Epirubicin—stomach cancer	0.000122	0.000953	CcSEcCtD
Trifluoperazine—Hypotension—Doxorubicin—stomach cancer	0.000121	0.000948	CcSEcCtD
Trifluoperazine—Fatigue—Epirubicin—stomach cancer	0.000121	0.000945	CcSEcCtD
Trifluoperazine—Constipation—Epirubicin—stomach cancer	0.00012	0.000937	CcSEcCtD
Trifluoperazine—Nausea—Capecitabine—stomach cancer	0.00012	0.000935	CcSEcCtD
Trifluoperazine—Urticaria—Methotrexate—stomach cancer	0.000119	0.00093	CcSEcCtD
Trifluoperazine—Body temperature increased—Methotrexate—stomach cancer	0.000118	0.000926	CcSEcCtD
Trifluoperazine—Insomnia—Doxorubicin—stomach cancer	0.000117	0.000917	CcSEcCtD
Trifluoperazine—Clozapine—HTR1A—stomach cancer	0.000117	0.0208	CrCbGaD
Trifluoperazine—Dyspnoea—Doxorubicin—stomach cancer	0.000116	0.000904	CcSEcCtD
Trifluoperazine—Somnolence—Doxorubicin—stomach cancer	0.000115	0.000902	CcSEcCtD
Trifluoperazine—Decreased appetite—Doxorubicin—stomach cancer	0.000113	0.000882	CcSEcCtD
Trifluoperazine—Fatigue—Doxorubicin—stomach cancer	0.000112	0.000874	CcSEcCtD
Trifluoperazine—Urticaria—Epirubicin—stomach cancer	0.000111	0.000871	CcSEcCtD
Trifluoperazine—Constipation—Doxorubicin—stomach cancer	0.000111	0.000867	CcSEcCtD
Trifluoperazine—Body temperature increased—Epirubicin—stomach cancer	0.000111	0.000866	CcSEcCtD
Trifluoperazine—Hypersensitivity—Methotrexate—stomach cancer	0.00011	0.000863	CcSEcCtD
Trifluoperazine—Chlorpromazine—HTR1A—stomach cancer	0.00011	0.0195	CrCbGaD
Trifluoperazine—Asthenia—Methotrexate—stomach cancer	0.000107	0.00084	CcSEcCtD
Trifluoperazine—Pruritus—Methotrexate—stomach cancer	0.000106	0.000829	CcSEcCtD
Trifluoperazine—Hypersensitivity—Epirubicin—stomach cancer	0.000103	0.000808	CcSEcCtD
Trifluoperazine—Urticaria—Doxorubicin—stomach cancer	0.000103	0.000806	CcSEcCtD
Trifluoperazine—Body temperature increased—Doxorubicin—stomach cancer	0.000103	0.000802	CcSEcCtD
Trifluoperazine—Asthenia—Epirubicin—stomach cancer	0.000101	0.000786	CcSEcCtD
Trifluoperazine—Pruritus—Epirubicin—stomach cancer	9.92e-05	0.000775	CcSEcCtD
Trifluoperazine—Dizziness—Methotrexate—stomach cancer	9.91e-05	0.000774	CcSEcCtD
Trifluoperazine—Hypersensitivity—Doxorubicin—stomach cancer	9.56e-05	0.000747	CcSEcCtD
Trifluoperazine—Acepromazine—ALB—stomach cancer	9.45e-05	0.0168	CrCbGaD
Trifluoperazine—Rash—Methotrexate—stomach cancer	9.45e-05	0.000738	CcSEcCtD
Trifluoperazine—Dermatitis—Methotrexate—stomach cancer	9.44e-05	0.000738	CcSEcCtD
Trifluoperazine—Headache—Methotrexate—stomach cancer	9.39e-05	0.000734	CcSEcCtD
Trifluoperazine—Asthenia—Doxorubicin—stomach cancer	9.31e-05	0.000728	CcSEcCtD
Trifluoperazine—Dizziness—Epirubicin—stomach cancer	9.27e-05	0.000725	CcSEcCtD
Trifluoperazine—Thioproperazine—ALB—stomach cancer	9.23e-05	0.0164	CrCbGaD
Trifluoperazine—Pruritus—Doxorubicin—stomach cancer	9.18e-05	0.000718	CcSEcCtD
Trifluoperazine—Pipotiazine—ALB—stomach cancer	9.08e-05	0.0162	CrCbGaD
Trifluoperazine—Thiothixene—ALB—stomach cancer	9.08e-05	0.0162	CrCbGaD
Trifluoperazine—Nausea—Methotrexate—stomach cancer	8.9e-05	0.000696	CcSEcCtD
Trifluoperazine—Rash—Epirubicin—stomach cancer	8.84e-05	0.000691	CcSEcCtD
Trifluoperazine—Dermatitis—Epirubicin—stomach cancer	8.83e-05	0.00069	CcSEcCtD
Trifluoperazine—Headache—Epirubicin—stomach cancer	8.78e-05	0.000687	CcSEcCtD
Trifluoperazine—Dizziness—Doxorubicin—stomach cancer	8.58e-05	0.000671	CcSEcCtD
Trifluoperazine—Nausea—Epirubicin—stomach cancer	8.33e-05	0.000651	CcSEcCtD
Trifluoperazine—Rash—Doxorubicin—stomach cancer	8.18e-05	0.000639	CcSEcCtD
Trifluoperazine—Dermatitis—Doxorubicin—stomach cancer	8.17e-05	0.000639	CcSEcCtD
Trifluoperazine—Headache—Doxorubicin—stomach cancer	8.13e-05	0.000635	CcSEcCtD
Trifluoperazine—Nausea—Doxorubicin—stomach cancer	7.71e-05	0.000602	CcSEcCtD
Trifluoperazine—Clomipramine—ALB—stomach cancer	7.18e-05	0.0128	CrCbGaD
Trifluoperazine—Chlorpromazine—ALB—stomach cancer	4.93e-05	0.00876	CrCbGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—stomach cancer	3.14e-06	1.59e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—stomach cancer	3.12e-06	1.58e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	3.12e-06	1.58e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	3.11e-06	1.57e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—MAPK3—stomach cancer	3.1e-06	1.57e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—MAPK3—stomach cancer	3.1e-06	1.57e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—STAT3—stomach cancer	3.1e-06	1.57e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—stomach cancer	3.09e-06	1.56e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—stomach cancer	3.08e-06	1.56e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SERPINE1—stomach cancer	3.08e-06	1.56e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SERPINE1—stomach cancer	3.08e-06	1.56e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCND1—stomach cancer	3.08e-06	1.56e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—RHOA—stomach cancer	3.07e-06	1.55e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—JUN—stomach cancer	3.07e-06	1.55e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—stomach cancer	3.05e-06	1.55e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—MAPK1—stomach cancer	3.05e-06	1.54e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—KRAS—stomach cancer	3.05e-06	1.54e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—KRAS—stomach cancer	3.05e-06	1.54e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—EGFR—stomach cancer	3.05e-06	1.54e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NOS3—stomach cancer	3.04e-06	1.54e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—stomach cancer	3.04e-06	1.54e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—stomach cancer	3.03e-06	1.53e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCND1—stomach cancer	3.03e-06	1.53e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—stomach cancer	3.02e-06	1.53e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—STAT3—stomach cancer	3.02e-06	1.53e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—JUN—stomach cancer	3.02e-06	1.53e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCND1—stomach cancer	3.02e-06	1.53e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—JUN—stomach cancer	3.01e-06	1.52e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—STAT3—stomach cancer	3.01e-06	1.52e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—STAT3—stomach cancer	3e-06	1.52e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—STAT3—stomach cancer	3e-06	1.52e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MMP9—stomach cancer	2.99e-06	1.51e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—HRAS—stomach cancer	2.98e-06	1.51e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CDKN1A—stomach cancer	2.98e-06	1.51e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCND1—stomach cancer	2.97e-06	1.5e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—RHOA—stomach cancer	2.97e-06	1.5e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—RHOA—stomach cancer	2.97e-06	1.5e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—JUN—stomach cancer	2.97e-06	1.5e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCND1—stomach cancer	2.96e-06	1.5e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MAPK3—stomach cancer	2.96e-06	1.5e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—JUN—stomach cancer	2.96e-06	1.5e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—MAPK1—stomach cancer	2.95e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—MAPK1—stomach cancer	2.95e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—EGFR—stomach cancer	2.95e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EGFR—stomach cancer	2.95e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NOS3—stomach cancer	2.94e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NOS3—stomach cancer	2.94e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—stomach cancer	2.94e-06	1.49e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—stomach cancer	2.93e-06	1.48e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	2.93e-06	1.48e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	2.92e-06	1.48e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CAV1—stomach cancer	2.91e-06	1.47e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MAPK8—stomach cancer	2.9e-06	1.47e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOA1—stomach cancer	2.9e-06	1.47e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—PIK3CA—stomach cancer	2.9e-06	1.47e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MAPK3—stomach cancer	2.89e-06	1.46e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—stomach cancer	2.89e-06	1.46e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ALB—stomach cancer	2.88e-06	1.46e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—KRAS—stomach cancer	2.88e-06	1.46e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MYC—stomach cancer	2.88e-06	1.46e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—stomach cancer	2.88e-06	1.46e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	2.87e-06	1.45e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MAPK3—stomach cancer	2.87e-06	1.45e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	2.87e-06	1.45e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MAPK3—stomach cancer	2.86e-06	1.45e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MAPK3—stomach cancer	2.86e-06	1.45e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MAPK8—stomach cancer	2.86e-06	1.45e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—stomach cancer	2.85e-06	1.44e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MAPK8—stomach cancer	2.85e-06	1.44e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ERBB2—stomach cancer	2.84e-06	1.44e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MAPK1—stomach cancer	2.82e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EGFR—stomach cancer	2.81e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MYC—stomach cancer	2.81e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MAPK8—stomach cancer	2.81e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PIK3CA—stomach cancer	2.8e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PIK3CA—stomach cancer	2.8e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	2.8e-06	1.42e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MYC—stomach cancer	2.8e-06	1.41e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—KRAS—stomach cancer	2.79e-06	1.41e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—KRAS—stomach cancer	2.79e-06	1.41e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MYC—stomach cancer	2.78e-06	1.41e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MYC—stomach cancer	2.78e-06	1.41e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.78e-06	1.41e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NOS3—stomach cancer	2.76e-06	1.39e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ERBB2—stomach cancer	2.75e-06	1.39e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ERBB2—stomach cancer	2.75e-06	1.39e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MAPK1—stomach cancer	2.75e-06	1.39e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EGFR—stomach cancer	2.75e-06	1.39e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MAPK1—stomach cancer	2.74e-06	1.38e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EGFR—stomach cancer	2.73e-06	1.38e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MAPK1—stomach cancer	2.72e-06	1.38e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MAPK1—stomach cancer	2.72e-06	1.38e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EGFR—stomach cancer	2.72e-06	1.38e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EGFR—stomach cancer	2.72e-06	1.38e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CXCL8—stomach cancer	2.7e-06	1.36e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—stomach cancer	2.68e-06	1.36e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—HRAS—stomach cancer	2.68e-06	1.36e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—KRAS—stomach cancer	2.66e-06	1.35e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—STAT3—stomach cancer	2.66e-06	1.34e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—PIK3CA—stomach cancer	2.65e-06	1.34e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—stomach cancer	2.64e-06	1.34e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1B—stomach cancer	2.63e-06	1.33e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—stomach cancer	2.63e-06	1.33e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—STAT3—stomach cancer	2.61e-06	1.32e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CXCL8—stomach cancer	2.61e-06	1.32e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CXCL8—stomach cancer	2.61e-06	1.32e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—STAT3—stomach cancer	2.61e-06	1.32e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—KRAS—stomach cancer	2.6e-06	1.31e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—HRAS—stomach cancer	2.59e-06	1.31e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—HRAS—stomach cancer	2.59e-06	1.31e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—stomach cancer	2.59e-06	1.31e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	2.58e-06	1.31e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—KRAS—stomach cancer	2.58e-06	1.31e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—KRAS—stomach cancer	2.57e-06	1.3e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—KRAS—stomach cancer	2.57e-06	1.3e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—STAT3—stomach cancer	2.57e-06	1.3e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—stomach cancer	2.56e-06	1.3e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—PIK3CA—stomach cancer	2.56e-06	1.3e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—PIK3CA—stomach cancer	2.56e-06	1.3e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—STAT3—stomach cancer	2.56e-06	1.29e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARG—stomach cancer	2.56e-06	1.29e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1B—stomach cancer	2.55e-06	1.29e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1B—stomach cancer	2.55e-06	1.29e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MAPK3—stomach cancer	2.54e-06	1.28e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—stomach cancer	2.52e-06	1.28e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCND1—stomach cancer	2.51e-06	1.27e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—JUN—stomach cancer	2.51e-06	1.27e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MAPK3—stomach cancer	2.5e-06	1.26e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MAPK3—stomach cancer	2.49e-06	1.26e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—stomach cancer	2.48e-06	1.26e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—stomach cancer	2.48e-06	1.26e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MYC—stomach cancer	2.47e-06	1.25e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MAPK3—stomach cancer	2.45e-06	1.24e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HRAS—stomach cancer	2.45e-06	1.24e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	2.44e-06	1.24e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PIK3CA—stomach cancer	2.44e-06	1.24e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—stomach cancer	2.44e-06	1.23e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1A—stomach cancer	2.43e-06	1.23e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCND1—stomach cancer	2.43e-06	1.23e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCND1—stomach cancer	2.43e-06	1.23e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MYC—stomach cancer	2.43e-06	1.23e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—JUN—stomach cancer	2.43e-06	1.23e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—JUN—stomach cancer	2.43e-06	1.23e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MYC—stomach cancer	2.42e-06	1.23e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MAPK1—stomach cancer	2.41e-06	1.22e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EGFR—stomach cancer	2.41e-06	1.22e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	2.39e-06	1.21e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MYC—stomach cancer	2.38e-06	1.21e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MYC—stomach cancer	2.38e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MAPK1—stomach cancer	2.38e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EGFR—stomach cancer	2.37e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	2.37e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MAPK8—stomach cancer	2.37e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MAPK1—stomach cancer	2.37e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EGFR—stomach cancer	2.37e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HRAS—stomach cancer	2.37e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HRAS—stomach cancer	2.37e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PIK3CA—stomach cancer	2.36e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PIK3CA—stomach cancer	2.36e-06	1.2e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—stomach cancer	2.36e-06	1.19e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—stomach cancer	2.36e-06	1.19e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1A—stomach cancer	2.35e-06	1.19e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1A—stomach cancer	2.35e-06	1.19e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—stomach cancer	2.34e-06	1.19e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MAPK1—stomach cancer	2.33e-06	1.18e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EGFR—stomach cancer	2.33e-06	1.18e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	2.33e-06	1.18e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EGFR—stomach cancer	2.33e-06	1.18e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—stomach cancer	2.31e-06	1.17e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ALB—stomach cancer	2.3e-06	1.16e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—stomach cancer	2.3e-06	1.16e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MAPK8—stomach cancer	2.29e-06	1.16e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MAPK8—stomach cancer	2.29e-06	1.16e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—KRAS—stomach cancer	2.28e-06	1.15e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—stomach cancer	2.27e-06	1.15e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—stomach cancer	2.27e-06	1.15e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—HRAS—stomach cancer	2.26e-06	1.14e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—KRAS—stomach cancer	2.24e-06	1.14e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—KRAS—stomach cancer	2.24e-06	1.13e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—HRAS—stomach cancer	2.21e-06	1.12e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—KRAS—stomach cancer	2.2e-06	1.11e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NOS3—stomach cancer	2.2e-06	1.11e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—KRAS—stomach cancer	2.2e-06	1.11e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—HRAS—stomach cancer	2.2e-06	1.11e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—stomach cancer	2.19e-06	1.11e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—HRAS—stomach cancer	2.19e-06	1.11e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—HRAS—stomach cancer	2.19e-06	1.11e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—STAT3—stomach cancer	2.17e-06	1.1e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—stomach cancer	2.16e-06	1.09e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—stomach cancer	2.12e-06	1.07e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—stomach cancer	2.12e-06	1.07e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—stomach cancer	2.11e-06	1.07e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—stomach cancer	2.1e-06	1.06e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—STAT3—stomach cancer	2.1e-06	1.06e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—STAT3—stomach cancer	2.1e-06	1.06e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PIK3CA—stomach cancer	2.09e-06	1.06e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—stomach cancer	2.09e-06	1.06e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—stomach cancer	2.09e-06	1.06e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MAPK3—stomach cancer	2.07e-06	1.05e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	2.06e-06	1.04e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	2.06e-06	1.04e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PIK3CA—stomach cancer	2.05e-06	1.04e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—stomach cancer	2.03e-06	1.03e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	2.02e-06	1.02e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	2.02e-06	1.02e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MYC—stomach cancer	2.02e-06	1.02e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—stomach cancer	2.01e-06	1.02e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MAPK3—stomach cancer	2e-06	1.01e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MAPK3—stomach cancer	2e-06	1.01e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—stomach cancer	1.99e-06	1.01e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—stomach cancer	1.99e-06	1.01e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3CA—stomach cancer	1.98e-06	1e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3CA—stomach cancer	1.98e-06	1e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MAPK1—stomach cancer	1.97e-06	9.98e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EGFR—stomach cancer	1.97e-06	9.97e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—stomach cancer	1.96e-06	9.91e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—stomach cancer	1.95e-06	9.88e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MYC—stomach cancer	1.95e-06	9.86e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MYC—stomach cancer	1.95e-06	9.86e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—HRAS—stomach cancer	1.94e-06	9.81e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MAPK1—stomach cancer	1.91e-06	9.65e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MAPK1—stomach cancer	1.91e-06	9.65e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EGFR—stomach cancer	1.91e-06	9.65e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EGFR—stomach cancer	1.91e-06	9.65e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—HRAS—stomach cancer	1.91e-06	9.65e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HRAS—stomach cancer	1.9e-06	9.63e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HRAS—stomach cancer	1.87e-06	9.47e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HRAS—stomach cancer	1.87e-06	9.45e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—KRAS—stomach cancer	1.86e-06	9.42e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—stomach cancer	1.85e-06	9.38e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—stomach cancer	1.82e-06	9.23e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—stomach cancer	1.82e-06	9.21e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KRAS—stomach cancer	1.8e-06	9.11e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KRAS—stomach cancer	1.8e-06	9.11e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—stomach cancer	1.79e-06	9.07e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—stomach cancer	1.79e-06	9.04e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CA—stomach cancer	1.71e-06	8.66e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—stomach cancer	1.66e-06	8.37e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CA—stomach cancer	1.65e-06	8.37e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CA—stomach cancer	1.65e-06	8.37e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—stomach cancer	1.6e-06	8.1e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—stomach cancer	1.6e-06	8.1e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HRAS—stomach cancer	1.58e-06	8.01e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CA—stomach cancer	1.55e-06	7.85e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HRAS—stomach cancer	1.53e-06	7.75e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HRAS—stomach cancer	1.53e-06	7.75e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—stomach cancer	1.51e-06	7.67e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—stomach cancer	1.47e-06	7.42e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—stomach cancer	1.47e-06	7.42e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.24e-06	6.26e-06	CbGpPWpGaD
